Alzheimer'
Conditions
Interventions
SPECT, MRI, neuropsychological tests
Sponsors
Nara medical university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: a) Dementia patients group 1. Outpatients of the psychiatric department of Nara medical university or Nara medical university hospital dementia-related disease medical center who are diagnosed as Alzheimer's disease or dementia with Lewy bodies based on DSM-5 2. < 85 years of age b) Healthy control group 1. No history or present diagnosis of any DSM-5 diagnosis or any neurological illness 2. Mini-Mental-State Examination (MMSE) >= 27 3. < 85 years of age
Exclusion criteria
Exclusion criteria: 1. A history of head injury 2. A diagnose of abuse or addiction of drugs 3. A diagnose or history of mental illness based on DSM-5 and neurological illness other than Alzheimer's disease or dementia with Lewy bodies for Dementia patients group 4. No consent ability
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We investigate the relationships between neuropsychiatric symptoms and MRI, SPECT, and neuropsychological tests in clinical use. | — |
Secondary
| Measure | Time frame |
|---|---|
| We investigate neuropsychiatric symptoms and MRI, SPECT, and neuropsychological tests of control subjects, for comparing with dementia patients. | — |
Countries
Japan
Contacts
Public ContactKiwamu Matsuoka
Nara medical university The department of psychiatry
Outcome results
None listed